✦ LIBER ✦

In vivo agonist properties of 7-hydroxy-N,N-di-n-propyl-2-aminotetralin, a dopamine D3-selective receptor ligand

✍ Scribed by John McElroy; Kim Zeller; Kelly Amy; Kathryn Ward; James Cawley; Amie Mazzola; William Keim; Kenneth Rohrbach

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 206 KB
Volume: 30
Category: Article
ISSN: 0272-4391
DOI: 10.1002/ddr.430300409

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Characterization of the dopamine D3 rece

Characterization of the dopamine D3 receptor agonist R(+)-7-hydroxy-N, N-di-n-propyl-2-aminotetralin-induced hypo- and hypermotility in mice

✍ Makoto Ukai; Hiroko Tamoto; Tomoko Tanaka; Tsutomu Kameyama 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 2 views

The present study was designed to characterize the dopamine D 3 receptor agonist R()-7-hydroxy-N,N-di-n-propyl-2-aminotetralin (R()-7-OH-DPAT)-induced changes in locomotor activity in mice. Although R()-7-OH-DPAT (0 . 01±10 mg/kg) produced a signi®cant decrease in horizontal and vertical motility wi

Synthesis of (+)-(R)- and (−)-(S)-trans-

Synthesis of (+)-(R)- and (−)-(S)-trans-8-hydroxy-2-[N-n-propyl-N-(3′-iodo-2′-propenyl)] aminotetralin: New 5-HT1A receptor ligands

✍ Zhi-Ping Zhuang; Mei-Ping Kung; William Clarke; Saul Maayani; Mu Mu; Hank F. Kun 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 690 KB

R, S)trans-8-Hydroxy-2-[N-n-propy1-N-(3'-iodo-2'-propeny1)amino]tetraralin 7, a new radioiodinated ligand based on 8-OH-DPAT, was reported as a potential ligand for 5-HTlA receptors. The optically active (+)-(R)-and (-)-(S)-7 were prepared to investigate the stereoselectivity of (R, 3-7. Racemic int

Synthesis, resolution and radioiodinatio

Synthesis, resolution and radioiodination of S(−)trans-5-hydroxy-2-[N-n-propyl-N-(3′-iodo-2′-propenyl)amino]tetralin-S(−)trans-5-OH-PIPAT: A new dopamine D2-like receptor ligand

✍ Sumalee Chumpradit; Mei-Ping Kung; Janet Vessotskie; Hank F. Kung 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 579 KB

## Abstract A new dopamine D2‐like receptor ligand, (__R,S__)__trans__‐5‐hydroxy‐2‐[N‐n‐propyl‐N‐(3′‐iodo‐2′‐propenyl)amino]tetralin ((__R,S)trans__‐5‐OH‐PIPAT, 3), based on high affinity dopamine receptor agonist 5‐hydroxy‐2‐[N,N‐(di‐n‐propyl)‐2‐amino]tetralin (5‐OH‐DPAT, 1). was prepared. The syn

N-0923, a selective dopamine D2 receptor

N-0923, a selective dopamine D2 receptor agonist, is efficacious in rat and monkey models of Parkinson's disease

✍ Dr. J. D. Belluzzi; E. F. Domino; J. M. May; K. S. Bankiewicz; D. A. McAfee 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 800 KB

## Abstract Certain aminotetralins are known to be potent dopamine D~2~ receptor agonists. N‐0923, [‐]2‐(N‐propyl‐N‐2‐thienylethylamino)‐5‐hydroxytetralin HCl, recognizes the high and low affinity states of the D~2~ receptor in membranes from bovine caudate with a K~low~ of 79 nM. The selectivity r

In vitro and in vivo evaluation of the b

In vitro and in vivo evaluation of the binding of the dopamine D2 receptor agonist 11C-(R,S)-5-hydroxy-2-(di-n-propylamino)tetralin in rodents and nonhuman primate

✍ Jogeshwar Mukherjee; Tanjore K. Narayanan; Bradley T. Christian; Bingzhi Shi; Ke 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB 👁 3 views

The in vitro autoradiographic binding characteristics as well as in vivo imaging characteristics of a dopamine D2 receptor agonist, (R,S)-2-(N-propyl-N-1Ј-11 Cpropyl)amino-5-hydroxytetralin ( 11 C-5-OH-DPAT), were studied. In 3 H-spiperone assays using rat striata, 5-OH-DPAT exhibited an affinity of

Synthesis of [N-methyl-11C]-3-[(6-dimeth

Synthesis of [N-methyl-11C]-3-[(6-dimethylamino)pyridin-3-yl]-2,5-dimethyl-N, N-dipropylpyrazolo[1,5-a]pyrimidine-7-amine: A potential PET ligand for in vivo imaging of CRF1 receptors

✍ J.S. Dileep Kumar; Vattoly J. Majo; Jaya Prabhakaran; Norman R. Simpson; Ronald 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 138 KB

## Abstract A convenient synthesis of [N‐methyl‐^11^C]‐3‐[(6‐dimethylamino)pyridin‐3‐yl]‐2,5‐dimethyl‐__N__,__N__‐dipropylpyrazolo[1,5‐a]pyrimidine‐7‐amine (R121920), a highly selective CRF~1~ antagonist has been developed as a potential PET ligand. 3 ‐ [(6 ‐ methylamino)pyridin ‐ 3 ‐ yl]‐2,5‐dimet